We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Following an investigation by the Medicines & Healthcare products Regulatory Agency (MHRA) a man from north London has been sentenced to 6 years in prison at Croydon Crown Court.
MHRA investigation reveals illegally supplied opiate painkillers, tranquillisers and medications intended for the treatment of cancer worth £280,490.
The MHRA has taken action to ensure product safety for patients supplied with total parenteral nutrition (TPN) bags from the Calea UK (part of Fresenius Kabi) manufacturing facility in Runcorn, Cheshire
Following a complex investigation spanning four and a half years, Lee Tomlinson was sentenced yesterday at Hove Trial Centre to 2 years, 10 months imprisonment for his involvement in laundering the proceeds of illegal sales …
Mile End man sent down for involvement in the illegal supply and sale of potentially dangerous unauthorised and prescription-only medicines and Class C drugs.
As a precautionary measure, patients taking certain types of prescription-only medicines for Parkinson’s (Neupro), epilepsy (Vimpat) and blood clots (Clexane) are asked to check to see if they have products from batches of m…
30 November 2015: an opportunity to hear from MHRA and experts from the CHM about how they support innovative medicines.
MHRA has today published its first blog.
Early collaboration with MHRA helps AstraZeneca to continue to supply critical cancer medicine.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).